GuzzettaNAAllenNNWilsonECFosterGSEhrlichACMillerBE. Excessive postoperative bleeding and outcomes in neonates undergoing cardiopulmonary bypass. Anesth Analg. 2015;120(2):405-410.
2.
BensonJWHraskaVScottJP,et al.Comparison of prothrombin complex concentrate to activated factor vii use for bleeding following cardiopulmonary bypass in children. World J Pediatr Congenit Heart Surg. 2023;14(2). doi:10.1177/21501351231162911
3.
HarperPCSmithMMBrinkmanNJ, et al.Outcomes following three-factor inactive prothrombin complex concentrate versus recombinant activated factor VII administration during cardiac surgery. J Cardiothorac Vasc Anesth. 2018;32(1):151-157.
4.
DowneyLBrownMLFaraoniDZurakowskiDDiNardoJA. Recombinant factor VIIa is associated with increased thrombotic complications in pediatric cardiac surgery patients. Anesth Analg. 2017;124(5):1431-1436.
5.
HarrisADHubbardRMSamRMZhangXSalazarJGautamNK. A retrospective analysis of the use of 3-factor prothrombin complex concentrates for refractory bleeding after cardiopulmonary bypass in children undergoing heart surgery: a matched case-control study. Semin Cardiothorac Vasc Anesth. 2020;24(3):227-231.
6.
LopesCTDos SantosTRBrunoriEHMoorheadSALopes JdeLBarrosAL. Excessive bleeding predictors after cardiac surgery in adults: integrative review. J Clin Nurs. 2015;24(21-22):3046-3062.
7.
FaraoniDWillemsARomlinBSBelisleSVan der LindenP. Development of a specific algorithm to guide haemostatic therapy in children undergoing cardiac surgery: a single-centre retrospective study. Eur J Anaesthesiol. 2015;32(5):320-329.
8.
NakayamaYNakajimaYTanakaKA,et al.Thromboelastometry-guided intraoperative haemostatic management reduces bleeding and red cell transfusion after paediatric cardiac surgery. Br J Anaesth. 2015;114(1):91-102.